FDA issues safety alert on breast implant-associated cancers
The Food and Drug Administration yesterday alerted health care providers and the public to reports of squamous cell carcinoma in scar tissue around breast implants, as well as lymphomas different than those previously associated with breast implants. The agency recommends that health care providers continue to report cancers around breast implants to help it identify and better understand this emerging issue.
Related News Articles
Headline
Jon Zifferblatt, M.D., executive vice president and chief strategy officer at West Health, and Diane Wintz, M.D., critical care specialist and medical director…
Headline
There have been 1,596 confirmed cases of measles across the U.S. this year, according to the latest data from the Centers for Disease Control and Prevention.…
Headline
Measles cases have been reported by 42 states and jurisdictions this year, with 1,563 total nationwide, according to the latest data released yesterday by the…
Headline
Inova Health System’s Toni Ardabell, chief of clinical enterprise operations, and Sage Bolte, Ph.D., chief philanthropy officer and president of the Inova…
Perspective
All of America’s hospitals and health systems, regardless of ownership status, size or location, provide a vast range of benefits, programs and essential…
Headline
Speakers interested in leading conversations and collaborations at the AHA’s new Healthier Together Conference are advised to submit a content proposal by Sept…